281 related articles for article (PubMed ID: 21927026)
1. Self-renewal gene tracking to identify tumour-initiating cells associated with metastatic potential.
Darini CY; Pisani DF; Hofman P; Pedeutour F; Sudaka I; Chomienne C; Dani C; Ladoux A
Oncogene; 2012 May; 31(19):2438-49. PubMed ID: 21927026
[TBL] [Abstract][Full Text] [Related]
2. CXC chemokine receptor 4 is essential for maintenance of renal cell carcinoma-initiating cells and predicts metastasis.
Gassenmaier M; Chen D; Buchner A; Henkel L; Schiemann M; Mack B; Schendel DJ; Zimmermann W; Pohla H
Stem Cells; 2013 Aug; 31(8):1467-76. PubMed ID: 23630186
[TBL] [Abstract][Full Text] [Related]
3. Screening for genes essential for mouse embryonic stem cell self-renewal using a subtractive RNA interference library.
Zhang JZ; Gao W; Yang HB; Zhang B; Zhu ZY; Xue YF
Stem Cells; 2006 Dec; 24(12):2661-8. PubMed ID: 16960129
[TBL] [Abstract][Full Text] [Related]
4. The reprogramming factor nuclear receptor subfamily 5, group A, member 2 cannot replace octamer-binding transcription factor 4 function in the self-renewal of embryonic stem cells.
Choi KW; Oh HR; Lee J; Lim B; Han YM; Oh J; Kim J
FEBS J; 2014 Feb; 281(4):1029-45. PubMed ID: 24341592
[TBL] [Abstract][Full Text] [Related]
5. A CD90(+) tumor-initiating cell population with an aggressive signature and metastatic capacity in esophageal cancer.
Tang KH; Dai YD; Tong M; Chan YP; Kwan PS; Fu L; Qin YR; Tsao SW; Lung HL; Lung ML; Tong DK; Law S; Chan KW; Ma S; Guan XY
Cancer Res; 2013 Apr; 73(7):2322-32. PubMed ID: 23382045
[TBL] [Abstract][Full Text] [Related]
6. Oct-3/4 expression reflects tumor progression and regulates motility of bladder cancer cells.
Chang CC; Shieh GS; Wu P; Lin CC; Shiau AL; Wu CL
Cancer Res; 2008 Aug; 68(15):6281-91. PubMed ID: 18676852
[TBL] [Abstract][Full Text] [Related]
7. Overlapping genes may control reprogramming of mouse somatic cells into induced pluripotent stem cells (iPSCs) and breast cancer stem cells.
Mosca E; Cocola C; Sabour D; Pelucchi P; Bertalot G; Palumbo O; Carella M; Götte M; Schöler HR; Reinbold R; Zucchi I; Milanesi L
In Silico Biol; 2010; 10(5-6):207-21. PubMed ID: 22430355
[TBL] [Abstract][Full Text] [Related]
8. An efficient transfection method for mouse embryonic stem cells.
Liou JY; Ko BS; Chang TC
Methods Mol Biol; 2010; 650():145-53. PubMed ID: 20686950
[TBL] [Abstract][Full Text] [Related]
9. Hypoxia and TP53 deficiency for induced pluripotent stem cell-like properties in gastrointestinal cancer.
Hoshino H; Nagano H; Haraguchi N; Nishikawa S; Tomokuni A; Kano Y; Fukusumi T; Saito T; Ozaki M; Sakai D; Satoh T; Eguchi H; Sekimoto M; Doki Y; Mori M; Ishii H
Int J Oncol; 2012 May; 40(5):1423-30. PubMed ID: 22293932
[TBL] [Abstract][Full Text] [Related]
10. SATB1 reprogrammes gene expression to promote breast tumour growth and metastasis.
Han HJ; Russo J; Kohwi Y; Kohwi-Shigematsu T
Nature; 2008 Mar; 452(7184):187-93. PubMed ID: 18337816
[TBL] [Abstract][Full Text] [Related]
11. Infantile haemangioma expresses embryonic stem cell markers.
Itinteang T; Tan ST; Brasch HD; Steel R; Best HA; Vishvanath A; Jia J; Day DJ
J Clin Pathol; 2012 May; 65(5):394-8. PubMed ID: 22447921
[TBL] [Abstract][Full Text] [Related]
12. CXCR4 knockdown by small interfering RNA abrogates breast tumor growth in vivo.
Lapteva N; Yang AG; Sanders DE; Strube RW; Chen SY
Cancer Gene Ther; 2005 Jan; 12(1):84-9. PubMed ID: 15472715
[TBL] [Abstract][Full Text] [Related]
13. Characterization of LMX-1A as a metastasis suppressor in cervical cancer.
Liu CY; Chao TK; Su PH; Lee HY; Shih YL; Su HY; Chu TY; Yu MH; Lin YW; Lai HC
J Pathol; 2009 Oct; 219(2):222-31. PubMed ID: 19644956
[TBL] [Abstract][Full Text] [Related]
14. Barrett's oesophageal adenocarcinoma encompasses tumour-initiating cells that do not express common cancer stem cell markers.
Grotenhuis BA; Dinjens WN; Wijnhoven BP; Sonneveld P; Sacchetti A; Franken PF; van Dekken H; Tilanus HW; van Lanschot JJ; Fodde R
J Pathol; 2010 Aug; 221(4):379-89. PubMed ID: 20549647
[TBL] [Abstract][Full Text] [Related]
15. Increased dosage of tumor suppressors limits the tumorigenicity of iPS cells without affecting their pluripotency.
Menendez S; Camus S; Herreria A; Paramonov I; Morera LB; Collado M; Pekarik V; Maceda I; Edel M; Consiglio A; Sanchez A; Li H; Serrano M; Belmonte JC
Aging Cell; 2012 Feb; 11(1):41-50. PubMed ID: 21981310
[TBL] [Abstract][Full Text] [Related]
16. The EWS-Oct-4 fusion gene encodes a transforming gene.
Lee J; Kim JY; Kang IY; Kim HK; Han YM; Kim J
Biochem J; 2007 Sep; 406(3):519-26. PubMed ID: 17564582
[TBL] [Abstract][Full Text] [Related]
17. Role of the tissue factor pathway in the biology of tumor initiating cells.
Garnier D; Milsom C; Magnus N; Meehan B; Weitz J; Yu J; Rak J
Thromb Res; 2010 Apr; 125 Suppl 2():S44-50. PubMed ID: 20434004
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical analysis of the role and relationship between Notch-1 and Oct-4 expression in urinary bladder carcinoma.
Abdou AG; El-Wahed MM; Kandil MA; Samaka RM; Elkady N
APMIS; 2013 Oct; 121(10):982-96. PubMed ID: 23594289
[TBL] [Abstract][Full Text] [Related]
19. Intratumoral heterogeneity in the self-renewal and tumorigenic differentiation of ovarian cancer.
Abelson S; Shamai Y; Berger L; Shouval R; Skorecki K; Tzukerman M
Stem Cells; 2012 Mar; 30(3):415-24. PubMed ID: 22267284
[TBL] [Abstract][Full Text] [Related]
20. GABPalpha regulates Oct-3/4 expression in mouse embryonic stem cells.
Kinoshita K; Ura H; Akagi T; Usuda M; Koide H; Yokota T
Biochem Biophys Res Commun; 2007 Feb; 353(3):686-91. PubMed ID: 17194449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
